Yahoo
NYSE - Nasdaq Real Time Price USD

Solventum Corporation (SOLV)

90.74 +3.56 (+4.08%)
As of 3:05:28 PM EST. Market Open.
Trade SOLV on Coinbase
SOLV Q3 2026 earnings call
Replay the call for the latest insights.
Read transcript

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Bryan C. Hanson
CEO & Director 4.93M -- 1967
Mr. Wayde D. McMillan
Executive VP & CFO 1.97M -- 1970
Ms. Amy Landucci
Chief Information & Digital Officer 1.66M -- 1975
Ms. Marcela A. Kirberger
Chief Corporate & Legal Affairs Officer & Corporate Secretary 1.6M -- 1967
Ms. Heather L. Knight
Chief Commercial Officer 2.26M -- 1972
Mr. Neil C. Zieselman
Senior VP, Controller & Chief Accounting Officer -- -- 1976
Ms. Amy Wakeham
Senior Vice President of Investor Relations & External Finance Communications -- -- --
Ms. Rachel H. Ellingson
Chief Strategy & Corporate Development Officer -- -- 1970
Ms. Tammy L. Gomez
Chief Human Resources Officer 1.12M -- 1973
Mr. Paul S. Harrington
Chief Supply Chain Officer -- -- 1970

Solventum Corporation

1750 Yankee Doodle Road
Eagan, MN 55121
United States
(651) 733-1110 https://www.solventum.com
Sector: 
Healthcare
Full Time Employees: 
20,584

Description

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Corporate Governance

Solventum Corporation’s ISS Governance QualityScore as of November 1, 2026 is 7. The pillar scores are Audit: 10; Board: 3; Shareholder Rights: 6; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 5, 2026 at 9:00 PM UTC

Solventum Corporation Earnings Date

Recent Events

November 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 29, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 27, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 27, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: